Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Incyte Corporation (INCY)

« Back to company index

INCY Chatter Timeline

Stock Ticker for INCY

Most Active Tweeters for INCY

UserTweets
@Tickeron 8
@MarcJacksonLA 7
@TradeWithAlerts 6
@sleekoptions 6
@FlashAlert_me 6

Recent Tweets for INCY

Tickeron @Tickeron
$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 4, 2021. View odds for this a… https://t.co/0PtagkjkzL
May 8th 2021, 9:05am
TradeWithAlerts @TradeWithAlerts
Nice Print for $INCY - Amount: $11,072,928.72 - to learn more, SIGNUP https://t.co/JWvlYbvmfL or get a training https://t.co/0L4k6hF6bT!
May 7th 2021, 8:05pm
stevedoc22 @stevedoc22
@DeepSouthDoctor The concern is that they do not have freedom to operate due to $INCY IP. Also, they are chronic screw-ups.
May 6th 2021, 8:05pm
MarcJacksonLA @MarcJacksonLA
$INCY Evercore Maintains Buy Rating On Incyte, $115 PT https://t.co/kkw8DQnIB8
May 6th 2021, 2:05pm
Jarvis_Alerts @Jarvis_Alerts
$INCY [Incyte]: Morgan Stanley Maintains Equal-Weight Lowers Price Target $86 --> 85 https://t.co/9DjGO6tIcC
May 6th 2021, 12:05pm
Tickeron @Tickeron
$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 4, 2021. View odds for this a… https://t.co/iYVPCE694D
May 6th 2021, 9:05am
adar170 @adar170
$INCY was -28% https://t.co/kLIe56fsls
May 6th 2021, 1:05am
InsiderForms @InsiderForms
$INCY Insider Dhanak Dashyant has Sold 396 Shares. Title :EVP; Chief Scientific Officer Total Cost: $33,818.4 Buy/S… https://t.co/kjmx4qudEZ
May 5th 2021, 8:05pm
fintel_io @fintel_io
Insider Dashyant Dhanak reports selling 396 shares of $INCY for a total cost of $33,818.40 https://t.co/14MCG8MJLZ
May 5th 2021, 8:05pm
TradeWithAlerts @TradeWithAlerts
Nice Print for $INCY - Amount: $9,912,948.00 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt!
May 5th 2021, 7:05pm
MarcJacksonLA @MarcJacksonLA
$INCY Oppenheimer Maintains Buy Rating On Incyte, $110 PT https://t.co/pCID8Wfkoo
May 5th 2021, 5:05pm
CSIMarket @CSIMarket
$INCY #StockMarket #yte released fiscal first quarter of 2021 Revenues on https://t.co/savSNTKlN1: INCY announced E… https://t.co/o6UgZhLT9Z
May 5th 2021, 12:05pm
SwingTradeBot @SwingTradeBot
$INCY technical alerts: Stochastic Sell Signal, Wide Range Bar, Fell Below 50 DMA, MACD Bearish S... https://t.co/w5vDMJe2Lv
May 5th 2021, 12:05pm
CHItraders @CHItraders
$INCY Morgan Stanley Maintains Equal-Weight on Incyte, Lowers Price Target to $85
May 5th 2021, 12:05pm
realmaciej @realmaciej
RT @semodough: $INCY catalysts from there side deck https://t.co/FmG9dvUlZ0
May 5th 2021, 7:05am
sleekoptions @sleekoptions
Peak profit for the last 6 expired option alerts for $INCY 15.56% | 1.48% | 18.57% | -98.48% | 52.08% | 159.58% |… https://t.co/oqAod4RLoo
May 5th 2021, 12:05am
sleekoptions @sleekoptions
$INCY - Last six months, 6 option alerts peaked above 100% after they were triggered by the algo… https://t.co/TkKDOqeb9K
May 5th 2021, 12:05am
sleekoptions @sleekoptions
$INCY - View historical options performance for INCY https://t.co/fBAay8o89T https://t.co/mMkuSiMQo6
May 5th 2021, 12:05am
MarcJacksonLA @MarcJacksonLA
$INCY Pharma company to pay $12.6M to settle kickback allegations https://t.co/oTzpeDYOMj
May 4th 2021, 11:05pm
CryptoNewswire @CryptoNewswire
Pharma company to pay $12.6M to settle kickback allegations - https://t.co/0WyZh2bfIP $INCY #trading #crypto #news
May 4th 2021, 10:05pm
sleekoptions @sleekoptions
$INCY stock trading volume up by +153.22% | 1,846,688 vs 729,281 https://t.co/ksN8HlN6pO
May 4th 2021, 8:05pm
EdgarInsider @EdgarInsider
New Form 10-Q [Quarterly Report] entry filed by $INCY INCYTE CORP https://t.co/ijDtXo0Agu
May 4th 2021, 8:05pm
fintel_io @fintel_io
$INCY / Incyte files form 10-Q https://t.co/Oc4NyYycjO
May 4th 2021, 8:05pm
SwingTradeBot @SwingTradeBot
50 DMA Support today: $INCY $KNSL ... https://t.co/aW7zteKP9U
May 4th 2021, 7:05pm
TradeWithAlerts @TradeWithAlerts
Nice Print for $INCY - Amount: $11,730,105.50 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt!
May 4th 2021, 7:05pm
Swing_Samurai @Swing_Samurai
$INCY: Sell-to-open a partial/starter SHORT position. Bullish Aggression Score: [hidden] / Bearish Aggression Score… https://t.co/dTYABUJJ8L
May 4th 2021, 7:05pm
AlertTrade @AlertTrade
DOWNwithEARNINGS: $INCY Incyte Corporation Common Stock https://t.co/PDXLLWRMEb ? TradeIdeas via ? https://t.co/VS8RO1bzXJ
May 4th 2021, 6:05pm
SiteFocusHQ @SiteFocusHQ
$INCY Earnings Intelligence Analysis of recent earnings identified Incyte Corp. (NASDAQ: INCY ) business focus on… https://t.co/AHGphCAGCr
May 4th 2021, 6:05pm
SeekingAlpha @SeekingAlpha
$INCY - Incyte Corporation's (INCY) CEO Hervé Hoppenot on Q1 2021 Results - Earnings Call Transcript.… https://t.co/pKjTUWuLGR
May 4th 2021, 6:05pm
newsfilterio @newsfilterio
Incyte's Q1 Jakafi Sales Hit By Pandemic; Reaffirms 2021 Guidance $INCY https://t.co/PqlGxuKzA0
May 4th 2021, 6:05pm
equity_newswire @equity_newswire
$INCY Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/wYsmIyWwlG
May 4th 2021, 5:05pm
EarningsAlley @EarningsAlley
Incyte Corporation $INCY held an earnings call on 5/4/2021. Here are the highlights:
May 4th 2021, 4:05pm
StckPro @StckPro
$INCY NEW ARTICLE : Incyte's Q1 Jakafi Sales Hit By Pandemic; Reaffirms 2021 Guidance https://t.co/PibwrHNU7G Get a… https://t.co/oSe74Q5Zoh
May 4th 2021, 4:05pm
SeekingAlpha @SeekingAlpha
$INCY - Incyte Corporation 2021 Q1 - Results - Earnings Call Presentation. https://t.co/3XKMPuWnId #stockmarket #finance #markets
May 4th 2021, 3:05pm
MarcJacksonLA @MarcJacksonLA
$INCY Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs | Business… https://t.co/yHOpimRJTY
May 4th 2021, 2:05pm
optioncharts @optioncharts
$INCY Max Pain=80.00. Maturity=05/21/2021. #maxpain #options https://t.co/hfpe0Iy6CV https://t.co/s8ZxCAZ3Pa
May 4th 2021, 2:05pm
Briefingcom @Briefingcom
$INCY: Incyte beats by $0.04, misses on revs; reaffirms FY21 guidance https://t.co/PraYbpAA4R
May 4th 2021, 1:05pm
glitchbotio @glitchbotio
RT @MarketCurrents: $INCY - Incyte posts mixed Q1 results, reaffirms guidance https://t.co/1n6Z8AoCTV
May 4th 2021, 12:05pm
MarketCurrents @MarketCurrents
$INCY - Incyte posts mixed Q1 results, reaffirms guidance https://t.co/1n6Z8AoCTV
May 4th 2021, 12:05pm
mikelbarun @mikelbarun
$INCY playing star wars music during their 1Q21 earnings call is the pick me up I didnt know I needed this morning
May 4th 2021, 11:05am
StockPods @StockPods
$INCY Earnings Call Today: 8:00 AM EST Webcast: https://t.co/CNiDdf5wPE Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99
May 4th 2021, 11:05am
earningsinfo @earningsinfo
$INCY Incyte Corp Q1 2021 Earnings Call https://t.co/GQPVciSy8i
May 4th 2021, 11:05am
mediasentiment @mediasentiment
$INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 376
May 4th 2021, 11:05am
mediasentiment @mediasentiment
$INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 375
May 4th 2021, 11:05am
BertrandBio @BertrandBio
$INCY no specific figure for $MOR tafasitamab/Monjuvi, just "good uptake by both academic and community physicians"… https://t.co/d8ieyJHen1
May 4th 2021, 11:05am
StockTexts @StockTexts
$INCY Incyte Corporation SEC Filing: Form 8-K https://t.co/sNcnosdBM0
May 4th 2021, 11:05am
Estimize @Estimize
Great work by Suntrust_115 who takes the win for $INCY beating 8 other analysts and the Wall Street Consensus - https://t.co/yXcR4cazfj
May 4th 2021, 11:05am
Estimize @Estimize
$INCY misses the Estimize EPS Consensus by 3c and the Estimize Revenue Consensus by $66.18M. Reports FQ1 earnings o… https://t.co/HBtaCxv5v7
May 4th 2021, 11:05am
Estimize @Estimize
$INCY reports FQ1 earnings of 67c EPS and $604.72M Revs - https://t.co/yDuYYVADP1
May 4th 2021, 11:05am
mediasentiment @mediasentiment
$INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 330
May 4th 2021, 11:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.